Recruiting NA Stroke

New treatment option for Stroke

Official title Meditation and Biofeedback to Improve Anxiety, Depression and Quality of Life in Inpatients After Stroke

ClinicalTrials.gov ID: NCT05845541

What this study is testing

What it's testing
The goal of this clinical trial is to investigate the impact of a technology-based meditation program in the inpatient stroke population. It will explore how this approach can support patient-centred, holistic, compassionate care by reducing symptoms of depression and anxiety and improving quality of life.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Adult (18 years and older)
  • Inpatient rehabilitation patients at St. John's Rehab
  • Experienced a stroke within the past two months prior to study enrollment
  • Identified as being at risk for depression and/or anxiety based on their scores on study screening tools
  • Able to comply with study requirements

You likely can't join if

  • Younger than 18 years old
  • Significant comorbidity including psychiatric or neurological disorder (not including premorbid depression or anxiety)
  • Inability to complete any of the outcome measures
  • Starting a new antidepressant or a change in antidepressant medication within the past 6 months
  • Inability to provide informed consent
  • For qualitative interviews, patients can have experienced a stroke within one year.
See the full eligibility criteria
Who can join
  • Adult (18 years and older)
  • Inpatient rehabilitation patients at St. John's Rehab
  • Experienced a stroke within the past two months prior to study enrollment
  • Identified as being at risk for depression and/or anxiety based on their scores on study screening tools
  • Able to comply with study requirements
What rules you out
  • Younger than 18 years old
  • Significant comorbidity including psychiatric or neurological disorder (not including premorbid depression or anxiety)
  • Inability to complete any of the outcome measures
  • Starting a new antidepressant or a change in antidepressant medication within the past 6 months
  • Inability to provide informed consent
  • For qualitative interviews, patients can have experienced a stroke within one year.
  • For focus groups, staff who work significantly with stroke patients at St. John's Rehab. Staff can be physicians, nurses, allied health.

The study team makes the final eligibility decision.

Where it's taking place

  • Toronto, Ontario, Canada

Compensation & support

A stipend or compensation may be offered.

Higher-pay potential.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.